Fourth follow-up: Whole-body CT showed no signs of recurrence or metastasis. Tumor marker levels: AFP, 4.4 ng/mL; CEA, 8.1 ng/mL; CA19-9, 15.7 U/mL; CA72-4, 10.04 U/mL. This evidence concerns the gene CEACAM5 and neoplasm.